课题基金 / 基金详情

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
糖原合酶激酶 3 抑制的靶向治疗致心律失常性右心室心肌病 (TARGETED-ARVC)
批准号:
474600
负责人:
Roberts Jason D
金额:
$49.71万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-07-01 至 2025-07-01

项目摘要

项目成果

Roberts Jason D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic form of heart disease characterized by abnormal replacement of heart tissue with scar and fat. Affected patients are vulnerable to heart failure, dangerous fast heart beats, and sudden de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Calcium Release Deficiency Syndrome: Establishing a Clinical Diagnostic Test and an International Registry
  • 批准号:
    478350
  • 项目类别:
    Operating Grants
  • 资助金额:
    $78.02万
  • 财政年份:
    2023
  • 负责人:
    Roberts Jason D
  • 依托单位:
Prize 202203PJT - RYR2-targeted Gene Therapies for Treating Catecholaminergic Polymorphic Ventricular Tachycardia
  • 批准号:
    467980
  • 项目类别:
    Operating Grants
  • 资助金额:
    $2.19万
  • 财政年份:
    2022
  • 负责人:
    Roberts Jason D
  • 依托单位:
RYR2-targeted Gene Therapies for Treating Catecholaminergic Polymorphic Ventricular Tachycardia
  • 批准号:
    461749
  • 项目类别:
    Operating Grants
  • 资助金额:
    $77.74万
  • 财政年份:
    2022
  • 负责人:
    Roberts Jason D
  • 依托单位:
Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
  • 批准号:
    466287
  • 项目类别:
    Operating Grants
  • 资助金额:
    $198.82万
  • 财政年份:
    2022
  • 负责人:
    Roberts Jason D
  • 依托单位:
海外基金